Fighting antimicrobial resistance
The development of bacterial resistance to antibiotics and hospital-acquired infections, as well as the emergence of new disease agents against which available antibiotics are ineffective, represent major public health concerns today.
Diagnostic tests play an essential role in curbing the spread of multidrug resistant bacteria. They help clinicians decide whether an antibiotic will cure an infection and choose the most appropriate treatment. In addition, these tests are a precious tool for healthcare authorities in epidemiological surveillance and prevention programs.
A world leader in microbiology and a pioneer in resistance detection and susceptibility testing, bioMérieux works closely with healthcare professionals in the three key areas of Infection Control: Prevention, Surveillance and Intervention.
World HAI Forum
A biennial event organized by bioMérieux at the Fondation Mérieux’s Conference Center, the World HAI Forum gathers the world’s leading specialists in the fields of antibiotic resistance and healthcare-associated infections. Experts from Europe, North and South America, and Asia, working in the fields of human and animal health, come together to determine the urgent measures that must be taken to control one of the most pressing issues confronting human health today: microbial resistance to antibiotics.
While most meetings focus on scientific developments retrospectively in an academic format, the World HAI Forum gives participating experts a chance to do prospective analysis of subjects that are not usually discussed. More time is devoted to sharing best practices, successes and failures in the fight against multidrug-resistant bacteria, as a basis for building effective action plans.
As part of our commitment to fight HAIs and microbial resistance, bioMérieux also organizes symposia around the world. In the past few years they have been held in countries including the United States, Belgium, the Netherlands, Portugal, Spain, China, Japan, Korea, Colombia and Saudi Arabia.
In response to the Millennium Development Goals defined by the United Nations, bioMérieux is focusing its efforts on HIV/AIDS, tuberculosis and malaria, drawing upon its expertise in infectious diseases.
In addition to these primary objectives, bioMérieux also develops diagnostic solutions to address other public health challenges, such as testing for emerging viruses.
Our goal is to give access to biological diagnostic techniques in developing countries leveraging our presence in over 150 countries worldwide through 41 subsidiaries and a network of distributors. In concrete terms, we participate in healthcare programs receiving the support of important donors*, large international organizations** or NGOs, aiming to make diagnostic tools available locally, train personnel in the utilization of these systems and ensure post-installation follow-up.
* Global Fund, World Bank, UNISAID, etc.
** WHO, Unicef, PAHO, etc.
Our Key Assets
- Our global presence, including limited resource countries. Our teams in the field provide assistance for lab installation, technical training as well as local follow-up for users.
- Our expertise and commitment in the field of infectious diseases allow us to provide diagnostic solutions of excellent quality in formats that meet the needs of different healthcare settings